SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318154-21-000019
Filing Date
2021-04-28
Accepted
2021-04-27 20:01:28
Documents
76
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q amgn-20210331.htm   iXBRL 10-Q 1938545
2 RULE 13A-14(A) CERTIFICATIONS amgn-ex31_2021331xq1.htm EX-31 19915
3 SECTION 1350 CERTIFICATIONS amgn-ex32_2021331xq1.htm EX-32 9570
  Complete submission text file 0000318154-21-000019.txt   8703415

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amgn-20210331.xsd EX-101.SCH 57400
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amgn-20210331_cal.xml EX-101.CAL 81766
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amgn-20210331_def.xml EX-101.DEF 335342
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amgn-20210331_lab.xml EX-101.LAB 668521
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amgn-20210331_pre.xml EX-101.PRE 457543
9 EXTRACTED XBRL INSTANCE DOCUMENT amgn-20210331_htm.xml XML 1717286
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37702 | Film No.: 21860967
SIC: 2836 Biological Products, (No Diagnostic Substances)